Literature DB >> 22527376

Prediction of early response to uterine arterial embolisation of adenomyosis: value of T2 signal intensity ratio of adenomyosis.

Dae Chul Jung1, Man Deuk Kim, Young Taik Oh, Jong Yun Won, Do Yun Lee.   

Abstract

OBJECTIVES: To identify imaging predictors for complete necrosis after uterine artery embolisation (UAE) via quantitative measurement of the signal intensity obtained from magnetic resonance imaging (MRI) of a patient with adenomyosis.
METHODS: The MRIs of 119 patients with uterine adenomyosis, who underwent UAE, were retrospectively evaluated. Each lesion was classified based on its location and morphology on MRI. Thickness and signal intensity were measured in each adenomyosis and in the rectus muscle on the T2-weighted sagittal plane, and the T2-weighted signal intensity ratio (T2SR) was calculated. MR parameters were then compared in patients showing complete response that achieved complete necrosis and incomplete response after UAE via univariate and multivariate analysis. Receiver operating characteristic (ROC) analysis was used to evaluate the diagnostic performance of the predictor using MR parameters for differentiating the complete from the incomplete response.
RESULTS: The complete necrosis rate was 66.4 % (79/119) after UAE for adenomyosis. Univariate and multivariate analysis results indicated that T2SR was associated significantly with complete necrosis (P = 0.012). Symptomatic adenomyosis with T2SR above 0.475 was associated with complete necrosis after UAE (sensitivity = 57.0, specificity = 70.0, area under the ROC curve [AUC] = 0.643).
CONCLUSION: T2SR of adenomyosis on pre-procedural MRI can be utilised as a predictor for early therapeutic response of UAE in adenomyosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22527376     DOI: 10.1007/s00330-012-2436-z

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  26 in total

1.  Junctional zone of the uterus: correlation of MR imaging and histologic examination of hysterectomy specimens.

Authors:  L M Scoutt; S D Flynn; D J Luthringer; T R McCauley; S M McCarthy
Journal:  Radiology       Date:  1991-05       Impact factor: 11.105

2.  The microvasculature of common uterine abnormalities, other than fibroids.

Authors:  J O Beilby; G Farrer-Brown; M H Tarbit
Journal:  J Obstet Gynaecol Br Commonw       Date:  1971-04

Review 3.  MR imaging findings of adenomyosis: correlation with histopathologic features and diagnostic pitfalls.

Authors:  Ken Tamai; Kaori Togashi; Tsuyoshi Ito; Nobuko Morisawa; Toshitaka Fujiwara; Takashi Koyama
Journal:  Radiographics       Date:  2005 Jan-Feb       Impact factor: 5.333

4.  Uterine artery embolization for symptomatic adenomyosis: a new technical development of the 1-2-3 protocol and predictive factors of MR imaging affecting outcomes.

Authors:  Man Deuk Kim; Yong Min Kim; Hyun Cheol Kim; Jung Hyun Cho; Hyung Gon Kang; Chan Lee; Hee Jin Kim; Jong Tae Lee
Journal:  J Vasc Interv Radiol       Date:  2011-03-05       Impact factor: 3.464

5.  Uterine artery embolization for the treatment of uterine leiomyomata midterm results.

Authors:  S C Goodwin; B McLucas; M Lee; G Chen; R Perrella; S Vedantham; S Muir; A Lai; J W Sayre; M DeLeon
Journal:  J Vasc Interv Radiol       Date:  1999-10       Impact factor: 3.464

Review 6.  Role of magnetic resonance imaging in patient selection for uterine artery embolization.

Authors:  M Cura; A Cura; A Bugnone
Journal:  Acta Radiol       Date:  2006-12       Impact factor: 1.990

7.  Uterine artery embolisation for symptomatic adenomyosis--mid-term results.

Authors:  M J Bratby; W J Walker
Journal:  Eur J Radiol       Date:  2008-02-15       Impact factor: 3.528

8.  Economic evaluation of uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial.

Authors:  Nicole A Volkers; Wouter J K Hehenkamp; Patrick Smit; Willem M Ankum; Jim A Reekers; Erwin Birnie
Journal:  J Vasc Interv Radiol       Date:  2008-07       Impact factor: 3.464

9.  MRI of adenomyosis: changes with uterine artery embolization.

Authors:  Yuri Kitamura; Sandra J Allison; Reena C Jha; James B Spies; Pamela A Flick; Susan M Ascher
Journal:  AJR Am J Roentgenol       Date:  2006-03       Impact factor: 3.959

10.  Long-term quality of life assessment among patients undergoing uterine fibroid embolization.

Authors:  Martin Popovic; Dominik Berzaczy; Stefan Puchner; Andreas Zadina; Johannes Lammer; Robert A Bucek
Journal:  AJR Am J Roentgenol       Date:  2009-07       Impact factor: 3.959

View more
  5 in total

1.  Can measurement of apparent diffusion coefficient before treatment predict the response to uterine artery embolization for adenomyosis?

Authors:  Yaewon Park; Man Deuk Kim; Dae Chul Jung; Shin Jae Lee; Gyoungmin Kim; Sung Il Park; Jong Yun Won; Do Yun Lee
Journal:  Eur Radiol       Date:  2014-12-07       Impact factor: 5.315

2.  Predisposing factors for predicting the therapeutic response of adenomyosis after uterine artery embolization: serum CA125 levels and accompanying endometriosis.

Authors:  Rui Zheng; Dan Zeng; Ting-Ting Wan; Wen-Bo Guo; Yan Guo; Ming-Juan Liu
Journal:  Diagn Interv Radiol       Date:  2018-11       Impact factor: 2.630

3.  Temporary Internal Iliac Artery Blockage versus Uterine Artery Embolization in Patients After Laparoscopic Pregnancy Tissue Removal Due to Cesarean Scar Pregnancy.

Authors:  Qian Zhao; Xue-Yu Sun; Shu-Qi Ma; Meng-Wei Miao; Gai-Ling Li; Jing-Lu Wang; Rui-Xia Guo; Liu-Xia Li
Journal:  Int J Gen Med       Date:  2022-01-11

4.  Outcomes in Adenomyosis Treated with Uterine Artery Embolization Are Associated with Lesion Vascularity: A Long-Term Follow-Up Study of 252 Cases.

Authors:  Jing Zhou; Li He; Ping Liu; Hui Duan; Hanze Zhang; Weili Li; Shipeng Gong; Guidong Su; Chunlin Chen
Journal:  PLoS One       Date:  2016-11-02       Impact factor: 3.240

5.  Uterine Artery Embolization for Leiomyomas and Adenomyosis: A Pictorial Essay Based on Our Experience from 1300 Cases.

Authors:  Man Deuk Kim
Journal:  Korean J Radiol       Date:  2019-10       Impact factor: 3.500

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.